Biotech startups scale through boards of Key Opinion Leaders
Erik Gatenholm · He 3D Prints Body Parts And Will Do $4m in 2016 with Erik Gatenholm of CellInk EP 241 · Apr 18, 2016 · at 5:42
CELLINK co-founder Erik Gatenholm discusses the necessity of establishing credibility and winning over Key Opinion Leaders when selling implantable biomedical products.
0:00 / 0:22exact quote · 23.0s
720p mp4 · rendered on demand · StarZero watermark
“And the KOLs is key opinion leaders. It's kind of a board and special board that you establish of key surgeons and doctors in your field. We're interested in implanting this into animals or into humans. So these are basically your go-to customers that you want to get excited and they will talk about your product. They will get this product into other surgeons hands.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Erik Gatenholm
CELLINK projects $4 million in total revenue for 2016
“Total 20 16 revenue, we're going to come up to approximately four four million dollars.”
Gatenholm: Swedish Series A rounds can be as small as $500,000
“A Swedish round a could be basically 500,000 dollars.”